Yahoo Poland Wyszukiwanie w Internecie

Zaloguj się

Search results

  1. www.ahajournals.org › doi › 10Management of Patients at Risk for and With Left Ventricular...

    15 wrz 2022 · Complete thrombus resolution was achieved in 62.3% (n=99) at a median of 103 days (interquartile range, 32–392 days). 17 Recurrence of thrombus or an increase in LV thrombus area was observed in 14.5% (n=23), a finding associated with poor adherence, prothrombotic conditions, and increased mortality. 17.

    • View EPUB

      (r·=™Z¢ÔþÛôn =Yj > h~}¤ÄŽ@ ]|Ÿög š×/|ë@¾l÷ †u¢ÚsÅCÈù?\yÓ©b...

    • Linda S. Williams

      These results were statistically significant compared with...

    • PDF/Epub

      PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...

    • Trial

      Background—The Randomized Evaluation of Long-term...

  2. www.ahajournals.org › doi › 10Clinical Outcome After Left Ventricular Thrombus Resolution: Who...

    17 kwi 2023 · Patients with left ventricular thrombus (LVT) resolution can have LVT recurrence and risk for thromboembolism. However, these outcomes after LVT resolution are not well known. We aimed to assess the prevalence, risk factors, and clinical outcomes for LVT recurrence in patients with LVT resolution to inform follow‐up and treatment.

  3. www.jacc.org › doi › 10Left Ventricular Thrombus: Contemporary Etiologies, Treatment ...

    Left ventricular (LV) thrombus is a feared complication of LV dysfunction associated with high rates of systemic embolism, morbidity, and mortality. Traditionally, LV thrombus has been associated with acute myocardial infarction (MI).

  4. www.jacc.org › doi › 10MANAGEMENT AND CLINICAL OUTCOMES OF LEFT VENTRICULAR THROMBUS

    LV thrombus resolution after 6 months was seen in 92 (79.3%) patients in the warfarin group and 32 (66.6%) patients in the NOAC group (p=0.08). Bleeding rates were similar amongst both groups (8% vs. 10%, p=0.768).

  5. pubmed.ncbi.nlm.nih.gov › 33850917Management of left ventricular thrombus: a narrative review

    Abstract. Left ventricular thrombus (LVT) is a serious complication of acute myocardial infarction (MI) and also non-ischemic cardiomyopathies. We performed a narrative literature review, manual-search of reference lists of included articles and relevant reviews.

  6. www.acc.org › 2022/09/23 › 13Management of Patients at Risk for and With LV Thrombus: Key...

    23 wrz 2022 · If OAC is initiated, a treatment duration might be 1–3 months, depending on bleeding risk. On the basis of reasonable data and evidence, post-MI patients with LV thrombus should be treated with OAC, typically for a duration of 3 months.

  7. www.jacc.org › doi › 10CONTEMPORARY ETIOLOGIES, TREATMENT STRATEGIES, AND OUTCOMES OF...

    In the contemporary era, the most common precipitating factor for LV thrombus is HF; most patients are not on GDMT at the time of diagnosis. Warfarin remains the most commonly prescribed anticoagulant. Efficacy and safety of DOACs in treatment of LV thrombus requires a prospective clinical trial.